FDA clears AI upgrade for Intuitive’s lung biopsy robot; Horizon and MMI advance surgical robotics

Intuitive Surgical has received FDA clearance for artificial intelligence and imaging updates to its Ion lung biopsy robot. The AI software enhances navigation during robot-assisted bronchoscopy by adjusting imaging in real time when lung nodules shift from their original CT scan locations. The company plans a limited rollout to gather user feedback before a broader U.S. launch in 2026. More than 900 Ion systems are currently installed across 10 countries.

In ophthalmology, Horizon Surgical Systems announced the first cataract surgery using its Polaris robotic platform, performed by Los Angeles surgeon Uday Devgan. The system is designed to improve precision and consistency in cataract procedures as Horizon advances toward FDA approval and commercialization.

Meanwhile, MMI completed initial neurosurgical cases in an FDA-approved trial using its Symani system to restore brain blood flow in Moyamoya disease patients, expanding its use in microsurgery applications.

14-10-2025